Imunon, INC. 8-K Filing

Key Financial Figures

• $0.01 — ch registered Common stock, par value $0.01 per share IMNN Nasdaq Capital Mark
• $3.61 — ng sold at a combined offering price of $3.61 per Share and Warrant. The Pre-funded W
• $3.6099 — ng sold at a combined offering price of $3.6099 per Pre-funded Warrant and Warrant. The
• $0.0001 — nded Warrants have an exercise price of $0.0001 and will be exercisable immediately and
• $3.482 — The Warrants have an exercise price of $3.482 per share and will be exercisable immed
• $7.0 million — receive gross proceeds of approximately $7.0 million from the Offering, before deducting pla

Filing Documents

• form8-k.htm (8-K) — 52KB
• ex4-1.htm (EX-4.1) — 127KB
• ex4-2.htm (EX-4.2) — 108KB
• ex5-1.htm (EX-5.1) — 14KB
• ex10-1.htm (EX-10.1) — 242KB
• ex99-1.htm (EX-99.1) — 15KB
• ex99-1_001.jpg (GRAPHIC) — 3KB
• ex5-1_001.jpg (GRAPHIC) — 65KB
• ex5-1_002.jpg (GRAPHIC) — 3KB
• 0001493152-25-029711.txt ( ) — 931KB
• imnn-20251229.xsd (EX-101.SCH) — 3KB
• imnn-20251229_lab.xml (EX-101.LAB) — 33KB
• imnn-20251229_pre.xml (EX-101.PRE) — 22KB
• form8-k_htm.xml (XML) — 3KB

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 4.1 Form of Pre-funded Warrant 4.2 Form of Warrant 5.1 Opinion of Covington & Burling LLP 10.1 Securities Purchase Agreement, dated as of December 29, 2025, by and among Imunon, Inc. and the purchaser party thereto 23.1 Consent of Covington & Burling LLP (contained in Exhibit 5.1 above) 99.1 Press Release of Imunon, Inc., dated December 30, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IMUNON, INC. Dated: December 31, 2025 By: /s/ Susan Eylward Susan Eylward General Counsel and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR